Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer Purpose: To identify predictors of biochemical outcome ...

Overview on the use of androgen deprivation therapy (ADT) added to salvage radiation therapy (SRT) for prostate cancer patients with biochemical recurrence after prostatectomy. Th ...

Researchers at Northwestern University have developed and piloted an ultrasensitive, automated immunoassay that is capable of detecting serum PSA at concentrations as low as 330 fg/ml—approximately ...

Biochemical failure is defined differently for patients with localized prostate cancer treated with radical prostatectomy or radiotherapy, which has confounded comparison of these treatment modalities ...

A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to ...

Localized therapy for prostate cancer is often curative; however, 20% to 30% of patients experience a recurrence. Men with biochemical recurrence (BCR) are typically identified following routine ...

Credit: Getty Images Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer. Investigators have identified ...

The use of Nardil (phenelzine), a medication commonly prescribed to treat depression, appeared safe and well tolerated in patients with biochemical recurrent (BCR) prostate cancer, according to ...

Results from a surrogacy analysis of the NRG-RTOG 9601 trial indicated that biochemical failure was not an adequate surrogate endpoint for overall survival for patients with recurrent prostate cancer ...

Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment ...